Your browser doesn't support javascript.
loading
A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.
Eustace, Amanda; Mani, Navin; Span, Paul N; Irlam, Joely J; Taylor, Janet; Betts, Guy N J; Denley, Helen; Miller, Crispin J; Homer, Jarrod J; Rojas, Ana M; Hoskin, Peter J; Buffa, Francesca M; Harris, Adrian L; Kaanders, Johannes H A M; West, Catharine M L.
Affiliation
  • Eustace A; Translational Radiobiology Group, Institute of Cancer Sciences, University of Manchester, Christie Hospital, Manchester, United Kingdom.
Clin Cancer Res ; 19(17): 4879-88, 2013 Sep 01.
Article in En | MEDLINE | ID: mdl-23820108
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Cell Hypoxia / Gene Expression Regulation, Neoplastic / Laryngeal Neoplasms Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Cell Hypoxia / Gene Expression Regulation, Neoplastic / Laryngeal Neoplasms Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2013 Document type: Article Affiliation country: Country of publication: